Learn from the best in healthcare. We present you with real-time developments and actionable strategies. Register to ask your immediate questions and to access our slides.
We are extremely sorry for the technical difficulties that prevented us from streaming the webinar audio. We apologize to those who joined and were left waiting. We will reschedule the webinar as soon as possible. In the meantime, Richard, Alessandra, and Chloe are available to talk with each of you individually. Please look out for a new invite; we hope you can make it. Thank you for your patience and understanding.
Ahead of the American Society of Clinical Oncology's annual meeting, Avalere experts discussed the latest trends in policy, reimbursement, and market access reshaping oncology care.
Avalere experts hosted a lively discussion on current trends in digital health and the key steps necessary for stakeholders across the industry to successfully implement digital health initiatives.
Avalere experts hosted a lively discussion on the 2019 outlook for the medical device industry.
On January 10, Avalere experts examined the top healthcare priorities to watch in 2019.
Avalere experts examine the current drug pricing policy landscape and what potential changes stakeholders should prepare for.
Avalere experts discuss adult immunization rates in the United States and how the disparate coverage of vaccines under Medicare creates significant barriers to increasing adult immunization uptake.
Avalere experts are joined by Aledade CEO, Farzad Mostashari, MD, discussing the latest developments coming out of the Center for Medicare & Medicaid Innovation (CMMI).
Avalere experts discuss an evolving Medicaid program supported by a new administration and novel state approaches.
Avalere experts expand on significant priorities for 2018.
Avalere and Inovalon experts discuss the strategic advantages of leveraging our proprietary assets.
Learn more how analytics derived from proprietary commercial datasets empower provider executives to successfully partner across the healthcare industry.
Avalere experts discuss the need for unique stakeholder collaborations to facilitate success in the transition to a value-based care system.
Learn more about how new models of care are impacting providers as Avalere experts discuss care coordination and care transitions.
Avalere experts examine the challenges and successful approaches to outcomes-based contracts.
As the industry continues to see a shift from volume to value, Avalere experts examine the future of Medicare's Quality Payment Program under a new administration.
Avalere experts review proposed drug pricing policies from each stakeholder's perspective across the industry and the implications each might carry.
Avalere experts examine proposed key reforms to the ACA and its potential impacts.
Avalere experts discuss the top priorities to focus on as you navigate the new landscape.
With expanded administrative authority and flexibility to advance policy priorities through entities such as CMMI and IPAB, the new administration will shape the future of the Affordable Care Act, potential drug pricing reforms, and potential action on tax and/or entitlements.